Destination Therapy for End-Stage Heart Failure
Contact Information
(608) 263-0439
Related Conditions
Heart Failure (Cardiomyopathy)
Internet Resources
At UW Health Heart and Vascular Care in Madison, Wisconsin, we offer HeartMate® Destination Therapy (DT) to treat patients who suffer from end-stage heart failure (ESHF) and do not qualify for heart transplantation.Destination Therapy involves implanting the HeartMate® XVE left ventricular assist device (LVAD), the only device currently approved by the FDA as a long- term, permanent implant.
We are one of only two centers in Wisconsin and one of a handful in the nation with approval to implant this device as an alternative to transplantation. This further emphasizes our dedication to providing the most advanced treatment options for patients in Wisconsin and the Midwest.
Whether we implant a left ventricular assist device as a "bridge-to-transplantation" for those awaiting transplant, or as "Destination Therapy" for those ineligible for transplant, our results have been exemplary.
In addition, our multidisciplinary approach has enabled us to shorten the length of time our patients stay in the hospital after implantation. The unified effort between our doctors, nurses, coordinators and therapists means that patients are receiving the safest, most complete care possible.
About Left Ventricular Assist Devices
Left ventricular assist devices (LVADs) are implantable mechanical pumps. They assist the heart when it is not able to pump enough blood through the body.
The HeartMate XVE LVAS is one type of LVAD. Other LVADs include the Thoratec© VAD and the MicroMed Debakey VAD©. All three types of LVADs have been used at UW Health to help keep patients with end-stage heart failure alive while waiting for a transplant. This is called "bridge-to-transplant."
Unfortunately, many heart failure patients are not eligible for transplant. Reasons for ineligibility include:
- Advanced age
- Smoking
- Cancer
- Other health reasons
These patients in particular benefit from Destination Therapy. Some patients become eligible for transplant after the HeartMate LVAS is implanted.
Implanting the HeartMate® Left Ventricular Assist System (LVAS)
What to Expect After Left Ventricular Assist System Surgery
Discuss Your Options
Our Heart and Vascular Care specialists are available to discuss details of the Destination Therapy program and how it benefits end-stage heart failure patients not eligible for heart transplantation. For a referral, please call 608-263-0439.
